SNANF
Sona Nanotech Inc., nanotechnology life sciences company, manufactures and sells gold nanorod products for diagnostic tests. The company also provides Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic assay for the detection of the spike protein antigen from SARS-CoV-2 in saliva specimens from individuals, who are suspected of COVID-19; Gemini gold nanorods; Omni gold nanorods for medical applications; and contract services. Its products are used in various applications, including drug delivery, food and beverage testing, environmental testing, cell imaging, cancer treatment, and liposuction therapy, as well as medical and consumer, military, and veterinary diagnostics. The company is based in Halifax, Canada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.01 | $0 | -$537,684 |
| 2025 Q4 | -0.00 | $0 | -$339,820 |
| 2025 Q3 | -0.01 | $0 | -$404,457 |
| 2025 Q2 | -0.01 | $0 | -$798,922 |
| 2025 Q1 | -0.01 | $0 | -$417,527 |
| 2024 Q4 | -0.00 | $0 | -$1M |
| 2024 Q3 | -0.01 | $0 | -$7,740 |
| 2024 Q2 | -0.01 | $0 | -$122,879 |